Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
Abstract Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in eight patients with iris melanoma following robotic-assisted CyberKn...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e167f958b78a4d7e9e17836f0ebcad5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e167f958b78a4d7e9e17836f0ebcad5a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e167f958b78a4d7e9e17836f0ebcad5a2021-12-02T15:53:03ZRobotic assisted CyberKnife radiosurgery for the treatment of iris melanoma10.1038/s41598-021-84290-x2045-2322https://doaj.org/article/e167f958b78a4d7e9e17836f0ebcad5a2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84290-xhttps://doaj.org/toc/2045-2322Abstract Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in eight patients with iris melanoma following robotic-assisted CyberKnife treatment. Consecutive patients from the Department of Ophthalmology at University of Munich were included in the study if they had an iris melanoma that was treated with CyberKnife and had a minimum follow-up of 12 months. We evaluated tumor thickness, largest diameter, visual acuity and complications. 8 patients were included in this report. The median age was 74 years (range: 53–86 years). The median follow-up was 23 months (range 12–48 months). Tumor thickness decreased from 2.1 to 1.4 mm on average. Four out of eight patients showed stable or increased visual acuity compared to visual acuity at first visit. We did not find a correlation of applied radiation volume or radiation dose on visual outcome. Radiation keratopathy was the most common complication in five patients. No recurrences were noted. Robotic-assisted radiosurgery following CyberKnife is a promising non-invasive, single session treatment option for iris melanoma with comparable results regarding recurrence rate or complications to brachytherapy and proton beam therapy. All included patients showed good visual outcome.Valerie SchmelterSarah HeidornAlexander MuacevicSiegfried G. PriglingerPaul FoersterRaffael LieglNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Valerie Schmelter Sarah Heidorn Alexander Muacevic Siegfried G. Priglinger Paul Foerster Raffael Liegl Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma |
description |
Abstract Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in eight patients with iris melanoma following robotic-assisted CyberKnife treatment. Consecutive patients from the Department of Ophthalmology at University of Munich were included in the study if they had an iris melanoma that was treated with CyberKnife and had a minimum follow-up of 12 months. We evaluated tumor thickness, largest diameter, visual acuity and complications. 8 patients were included in this report. The median age was 74 years (range: 53–86 years). The median follow-up was 23 months (range 12–48 months). Tumor thickness decreased from 2.1 to 1.4 mm on average. Four out of eight patients showed stable or increased visual acuity compared to visual acuity at first visit. We did not find a correlation of applied radiation volume or radiation dose on visual outcome. Radiation keratopathy was the most common complication in five patients. No recurrences were noted. Robotic-assisted radiosurgery following CyberKnife is a promising non-invasive, single session treatment option for iris melanoma with comparable results regarding recurrence rate or complications to brachytherapy and proton beam therapy. All included patients showed good visual outcome. |
format |
article |
author |
Valerie Schmelter Sarah Heidorn Alexander Muacevic Siegfried G. Priglinger Paul Foerster Raffael Liegl |
author_facet |
Valerie Schmelter Sarah Heidorn Alexander Muacevic Siegfried G. Priglinger Paul Foerster Raffael Liegl |
author_sort |
Valerie Schmelter |
title |
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma |
title_short |
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma |
title_full |
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma |
title_fullStr |
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma |
title_full_unstemmed |
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma |
title_sort |
robotic assisted cyberknife radiosurgery for the treatment of iris melanoma |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e167f958b78a4d7e9e17836f0ebcad5a |
work_keys_str_mv |
AT valerieschmelter roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma AT sarahheidorn roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma AT alexandermuacevic roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma AT siegfriedgpriglinger roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma AT paulfoerster roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma AT raffaelliegl roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma |
_version_ |
1718385542704398336 |